AYTU BIOPHARMA INC
AYTU · NASDAQ
Updated at 2026-10-14 09:27:48
- Today's High
- $2.03
- Today’s Low
- $1.95
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $1.99
- Previous Close
- $1.97
- Volume
- 23.24K
- Market Cap
- $21.4M
- P/E Ratio
- --
- EPS
- $-1.48
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Pharmaceuticals
- Sub-industry
- DRUG MANUFACTURERS - SPECIALTY & GENERIC
- Headquarters
- 7900 EAST UNION AVENUE, DENVER, CO, UNITED STATES, 80237
- Country
- US
- Listing Date
- 2017-10-20
- Fiscal Year End
- June
- Shares Outstanding
- 10.73M
- CIK
- 0001385818
- Website
- aytubio.com
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and marketing novel products in the field of hypogonadism (low testosterone levels), cough and upper respiratory symptoms, insomnia, and male infertility in the United States and internationally. The company is headquartered in Englewood, Colorado.
Financial Metrics
Revenue
2026-06-30
$16.1M
2026-03-31
$12.41M
2025-12-31
$15.16M
2025-09-30
$13.88M
Operating Expenses
2026-06-30
$12.47M
2026-03-31
$10.9M
2025-12-31
$11.06M
2025-09-30
$10.69M
Net Income
2026-06-30
-$15K
2026-03-31
-$5.61M
2025-12-31
-$10.58M
2025-09-30
$1.96M
Net Profit Margin
2026-06-30
-0.09%
2026-03-31
-45.26%
2025-12-31
-69.79%
2025-09-30
14.14%
Earnings Per Share
2026-06-30
$-0.05
2026-03-31
$-0.41
2025-12-31
$-0.23
2025-09-30
$-0.09
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
$1.42M
2026-03-31
-$4.05M
2025-12-31
-$9.13M
2025-09-30
$3.28M
Effective Tax Rate
2026-06-30
275%
2026-03-31
-0.17%
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $16.1M | $12.41M | $15.16M | $13.88M |
| Operating Expenses | $12.47M | $10.9M | $11.06M | $10.69M |
| Net Income | -$15K | -$5.61M | -$10.58M | $1.96M |
| Net Profit Margin | -0.09% | -45.26% | -69.79% | 14.14% |
| Earnings Per Share | $-0.05 | $-0.41 | $-0.23 | $-0.09 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | $1.42M | -$4.05M | -$9.13M | $3.28M |
| Effective Tax Rate | 275% | -0.17% | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.